1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global NSCLC Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Oral Type 1.2.3 Injection Type 1.3 Market by Application 1.3.1 Global NSCLC Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Squamous Cell Lung Carcinoma 1.3.3 Large-cell Lung Carcinoma 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global NSCLC Drugs Market Perspective (2016-2027) 2.2 NSCLC Drugs Growth Trends by Regions 2.2.1 NSCLC Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 NSCLC Drugs Historic Market Share by Regions (2016-2021) 2.2.3 NSCLC Drugs Forecasted Market Size by Regions (2022-2027) 2.3 NSCLC Drugs Industry Dynamic 2.3.1 NSCLC Drugs Market Trends 2.3.2 NSCLC Drugs Market Drivers 2.3.3 NSCLC Drugs Market Challenges 2.3.4 NSCLC Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top NSCLC Drugs Players by Revenue 3.1.1 Global Top NSCLC Drugs Players by Revenue (2016-2021) 3.1.2 Global NSCLC Drugs Revenue Market Share by Players (2016-2021) 3.2 Global NSCLC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by NSCLC Drugs Revenue 3.4 Global NSCLC Drugs Market Concentration Ratio 3.4.1 Global NSCLC Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by NSCLC Drugs Revenue in 2020 3.5 NSCLC Drugs Key Players Head office and Area Served 3.6 Key Players NSCLC Drugs Product Solution and Service 3.7 Date of Enter into NSCLC Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 NSCLC Drugs Breakdown Data by Type 4.1 Global NSCLC Drugs Historic Market Size by Type (2016-2021) 4.2 Global NSCLC Drugs Forecasted Market Size by Type (2022-2027) 5 NSCLC Drugs Breakdown Data by Application 5.1 Global NSCLC Drugs Historic Market Size by Application (2016-2021) 5.2 Global NSCLC Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America NSCLC Drugs Market Size (2016-2027) 6.2 North America NSCLC Drugs Market Size by Type 6.2.1 North America NSCLC Drugs Market Size by Type (2016-2021) 6.2.2 North America NSCLC Drugs Market Size by Type (2022-2027) 6.2.3 North America NSCLC Drugs Market Size by Type (2016-2027) 6.3 North America NSCLC Drugs Market Size by Application 6.3.1 North America NSCLC Drugs Market Size by Application (2016-2021) 6.3.2 North America NSCLC Drugs Market Size by Application (2022-2027) 6.3.3 North America NSCLC Drugs Market Size by Application (2016-2027) 6.4 North America NSCLC Drugs Market Size by Country 6.4.1 North America NSCLC Drugs Market Size by Country (2016-2021) 6.4.2 North America NSCLC Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe NSCLC Drugs Market Size (2016-2027) 7.2 Europe NSCLC Drugs Market Size by Type 7.2.1 Europe NSCLC Drugs Market Size by Type (2016-2021) 7.2.2 Europe NSCLC Drugs Market Size by Type (2022-2027) 7.2.3 Europe NSCLC Drugs Market Size by Type (2016-2027) 7.3 Europe NSCLC Drugs Market Size by Application 7.3.1 Europe NSCLC Drugs Market Size by Application (2016-2021) 7.3.2 Europe NSCLC Drugs Market Size by Application (2022-2027) 7.3.3 Europe NSCLC Drugs Market Size by Application (2016-2027) 7.4 Europe NSCLC Drugs Market Size by Country 7.4.1 Europe NSCLC Drugs Market Size by Country (2016-2021) 7.4.2 Europe NSCLC Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific NSCLC Drugs Market Size (2016-2027) 8.2 Asia-Pacific NSCLC Drugs Market Size by Type 8.2.1 Asia-Pacific NSCLC Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific NSCLC Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific NSCLC Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific NSCLC Drugs Market Size by Application 8.3.1 Asia-Pacific NSCLC Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific NSCLC Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific NSCLC Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific NSCLC Drugs Market Size by Region 8.4.1 Asia-Pacific NSCLC Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific NSCLC Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America NSCLC Drugs Market Size (2016-2027) 9.2 Latin America NSCLC Drugs Market Size by Type 9.2.1 Latin America NSCLC Drugs Market Size by Type (2016-2021) 9.2.2 Latin America NSCLC Drugs Market Size by Type (2022-2027) 9.2.3 Latin America NSCLC Drugs Market Size by Type (2016-2027) 9.3 Latin America NSCLC Drugs Market Size by Application 9.3.1 Latin America NSCLC Drugs Market Size by Application (2016-2021) 9.3.2 Latin America NSCLC Drugs Market Size by Application (2022-2027) 9.3.3 Latin America NSCLC Drugs Market Size by Application (2016-2027) 9.4 Latin America NSCLC Drugs Market Size by Country 9.4.1 Latin America NSCLC Drugs Market Size by Country (2016-2021) 9.4.2 Latin America NSCLC Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa NSCLC Drugs Market Size (2016-2027) 10.2 Middle East & Africa NSCLC Drugs Market Size by Type 10.2.1 Middle East & Africa NSCLC Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa NSCLC Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa NSCLC Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa NSCLC Drugs Market Size by Application 10.3.1 Middle East & Africa NSCLC Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa NSCLC Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa NSCLC Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa NSCLC Drugs Market Size by Country 10.4.1 Middle East & Africa NSCLC Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa NSCLC Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck NSCLC Drugs Introduction 11.1.4 Merck Revenue in NSCLC Drugs Business (2016-2021) 11.1.5 Merck Recent Development 11.2 Bristol-Myers Squibb 11.2.1 Bristol-Myers Squibb Company Details 11.2.2 Bristol-Myers Squibb Business Overview 11.2.3 Bristol-Myers Squibb NSCLC Drugs Introduction 11.2.4 Bristol-Myers Squibb Revenue in NSCLC Drugs Business (2016-2021) 11.2.5 Bristol-Myers Squibb Recent Development 11.3 Regeneron Pharmaceuticals 11.3.1 Regeneron Pharmaceuticals Company Details 11.3.2 Regeneron Pharmaceuticals Business Overview 11.3.3 Regeneron Pharmaceuticals NSCLC Drugs Introduction 11.3.4 Regeneron Pharmaceuticals Revenue in NSCLC Drugs Business (2016-2021) 11.3.5 Regeneron Pharmaceuticals Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis NSCLC Drugs Introduction 11.4.4 Novartis Revenue in NSCLC Drugs Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 Jiangsu Hengrui Medicine 11.5.1 Jiangsu Hengrui Medicine Company Details 11.5.2 Jiangsu Hengrui Medicine Business Overview 11.5.3 Jiangsu Hengrui Medicine NSCLC Drugs Introduction 11.5.4 Jiangsu Hengrui Medicine Revenue in NSCLC Drugs Business (2016-2021) 11.5.5 Jiangsu Hengrui Medicine Recent Development 11.6 Innovent Biologics 11.6.1 Innovent Biologics Company Details 11.6.2 Innovent Biologics Business Overview 11.6.3 Innovent Biologics NSCLC Drugs Introduction 11.6.4 Innovent Biologics Revenue in NSCLC Drugs Business (2016-2021) 11.6.5 Innovent Biologics Recent Development 11.7 Shanghai Junshi Biosciences 11.7.1 Shanghai Junshi Biosciences Company Details 11.7.2 Shanghai Junshi Biosciences Business Overview 11.7.3 Shanghai Junshi Biosciences NSCLC Drugs Introduction 11.7.4 Shanghai Junshi Biosciences Revenue in NSCLC Drugs Business (2016-2021) 11.7.5 Shanghai Junshi Biosciences Recent Development 11.8 BeiGene 11.8.1 BeiGene Company Details 11.8.2 BeiGene Business Overview 11.8.3 BeiGene NSCLC Drugs Introduction 11.8.4 BeiGene Revenue in NSCLC Drugs Business (2016-2021) 11.8.5 BeiGene Recent Development 11.9 Roche 11.9.1 Roche Company Details 11.9.2 Roche Business Overview 11.9.3 Roche NSCLC Drugs Introduction 11.9.4 Roche Revenue in NSCLC Drugs Business (2016-2021) 11.9.5 Roche Recent Development 11.10 AstraZeneca 11.10.1 AstraZeneca Company Details 11.10.2 AstraZeneca Business Overview 11.10.3 AstraZeneca NSCLC Drugs Introduction 11.10.4 AstraZeneca Revenue in NSCLC Drugs Business (2016-2021) 11.10.5 AstraZeneca Recent Development 11.11 Pfizer 11.11.1 Pfizer Company Details 11.11.2 Pfizer Business Overview 11.11.3 Pfizer NSCLC Drugs Introduction 11.11.4 Pfizer Revenue in NSCLC Drugs Business (2016-2021) 11.11.5 Pfizer Recent Development 11.12 Boehringer-Ingelheim 11.12.1 Boehringer-Ingelheim Company Details 11.12.2 Boehringer-Ingelheim Business Overview 11.12.3 Boehringer-Ingelheim NSCLC Drugs Introduction 11.12.4 Boehringer-Ingelheim Revenue in NSCLC Drugs Business (2016-2021) 11.12.5 Boehringer-Ingelheim Recent Development 11.13 Teva 11.13.1 Teva Company Details 11.13.2 Teva Business Overview 11.13.3 Teva NSCLC Drugs Introduction 11.13.4 Teva Revenue in NSCLC Drugs Business (2016-2021) 11.13.5 Teva Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global NSCLC Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Oral Type Table 3. Key Players of Injection Type Table 4. Global NSCLC Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global NSCLC Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global NSCLC Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global NSCLC Drugs Market Share by Regions (2016-2021) Table 8. Global NSCLC Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global NSCLC Drugs Market Share by Regions (2022-2027) Table 10. NSCLC Drugs Market Trends Table 11. NSCLC Drugs Market Drivers Table 12. NSCLC Drugs Market Challenges Table 13. NSCLC Drugs Market Restraints Table 14. Global NSCLC Drugs Revenue by Players (2016-2021) & (US$ Million) Table 15. Global NSCLC Drugs Market Share by Players (2016-2021) Table 16. Global Top NSCLC Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSCLC Drugs as of 2020) Table 17. Ranking of Global Top NSCLC Drugs Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by NSCLC Drugs Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players NSCLC Drugs Product Solution and Service Table 21. Date of Enter into NSCLC Drugs Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global NSCLC Drugs Market Size by Type (2016-2021) (US$ Million) Table 24. Global NSCLC Drugs Revenue Market Share by Type (2016-2021) Table 25. Global NSCLC Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global NSCLC Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global NSCLC Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global NSCLC Drugs Revenue Market Share by Application (2016-2021) Table 29. Global NSCLC Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global NSCLC Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America NSCLC Drugs Market Size by Type (2016-2021) (US$ Million) Table 32. North America NSCLC Drugs Market Size by Type (2022-2027) & (US$ Million) Table 33. North America NSCLC Drugs Market Size by Application (2016-2021) (US$ Million) Table 34. North America NSCLC Drugs Market Size by Application (2022-2027) & (US$ Million) Table 35. North America NSCLC Drugs Market Size by Country (2016-2021) & (US$ Million) Table 36. North America NSCLC Drugs Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe NSCLC Drugs Market Size by Type (2016-2021) (US$ Million) Table 38. Europe NSCLC Drugs Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe NSCLC Drugs Market Size by Application (2016-2021) (US$ Million) Table 40. Europe NSCLC Drugs Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe NSCLC Drugs Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe NSCLC Drugs Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific NSCLC Drugs Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific NSCLC Drugs Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific NSCLC Drugs Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific NSCLC Drugs Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific NSCLC Drugs Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific NSCLC Drugs Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America NSCLC Drugs Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America NSCLC Drugs Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America NSCLC Drugs Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America NSCLC Drugs Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America NSCLC Drugs Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America NSCLC Drugs Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa NSCLC Drugs Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa NSCLC Drugs Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa NSCLC Drugs Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa NSCLC Drugs Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa NSCLC Drugs Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa NSCLC Drugs Market Size by Country (2022-2027) & (US$ Million) Table 61. Merck Company Details Table 62. Merck Business Overview Table 63. Merck NSCLC Drugs Product Table 64. Merck Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 65. Merck Recent Development Table 66. Bristol-Myers Squibb Company Details Table 67. Bristol-Myers Squibb Business Overview Table 68. Bristol-Myers Squibb NSCLC Drugs Product Table 69. Bristol-Myers Squibb Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 70. Bristol-Myers Squibb Recent Development Table 71. Regeneron Pharmaceuticals Company Details Table 72. Regeneron Pharmaceuticals Business Overview Table 73. Regeneron Pharmaceuticals NSCLC Drugs Product Table 74. Regeneron Pharmaceuticals Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 75. Regeneron Pharmaceuticals Recent Development Table 76. Novartis Company Details Table 77. Novartis Business Overview Table 78. Novartis NSCLC Drugs Product Table 79. Novartis Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 80. Novartis Recent Development Table 81. Jiangsu Hengrui Medicine Company Details Table 82. Jiangsu Hengrui Medicine Business Overview Table 83. Jiangsu Hengrui Medicine NSCLC Drugs Product Table 84. Jiangsu Hengrui Medicine Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 85. Jiangsu Hengrui Medicine Recent Development Table 86. Innovent Biologics Company Details Table 87. Innovent Biologics Business Overview Table 88. Innovent Biologics NSCLC Drugs Product Table 89. Innovent Biologics Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 90. Innovent Biologics Recent Development Table 91. Shanghai Junshi Biosciences Company Details Table 92. Shanghai Junshi Biosciences Business Overview Table 93. Shanghai Junshi Biosciences NSCLC Drugs Product Table 94. Shanghai Junshi Biosciences Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 95. Shanghai Junshi Biosciences Recent Development Table 96. BeiGene Company Details Table 97. BeiGene Business Overview Table 98. BeiGene Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 99. BeiGene Recent Development Table 100. Roche Company Details Table 101. Roche Business Overview Table 102. Roche NSCLC Drugs Product Table 103. Roche Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 104. Roche Recent Development Table 105. AstraZeneca Company Details Table 106. AstraZeneca Business Overview Table 107. AstraZeneca NSCLC Drugs Product Table 108. AstraZeneca Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 109. AstraZeneca Recent Development Table 110. Pfizer Company Details Table 111. Pfizer Business Overview Table 112. Pfizer NSCLC Drugs Product Table 113. Pfizer Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 114. Pfizer Recent Development Table 115. Boehringer-Ingelheim Company Details Table 116. Boehringer-Ingelheim Business Overview Table 117. Boehringer-Ingelheim NSCLC Drugs Product Table 118. Boehringer-Ingelheim Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 119. Boehringer-Ingelheim Recent Development Table 120. Teva Company Details Table 121. Teva Business Overview Table 122. Teva NSCLC Drugs Product Table 123. Teva Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million) Table 124. Teva Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global NSCLC Drugs Market Share by Type: 2020 VS 2027 Figure 2. Oral Type Features Figure 3. Injection Type Features Figure 4. Global NSCLC Drugs Market Share by Application: 2020 VS 2027 Figure 5. Squamous Cell Lung Carcinoma Case Studies Figure 6. Large-cell Lung Carcinoma Case Studies Figure 7. NSCLC Drugs Report Years Considered Figure 8. Global NSCLC Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 9. Global NSCLC Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global NSCLC Drugs Market Share by Regions: 2020 VS 2027 Figure 11. Global NSCLC Drugs Market Share by Regions (2022-2027) Figure 12. Global NSCLC Drugs Market Share by Players in 2020 Figure 13. Global Top NSCLC Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSCLC Drugs as of 2020 Figure 14. The Top 10 and 5 Players Market Share by NSCLC Drugs Revenue in 2020 Figure 15. Global NSCLC Drugs Revenue Market Share by Type (2016-2021) Figure 16. Global NSCLC Drugs Revenue Market Share by Type (2022-2027) Figure 17. North America NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 18. North America NSCLC Drugs Market Share by Type (2016-2027) Figure 19. North America NSCLC Drugs Market Share by Application (2016-2027) Figure 20. North America NSCLC Drugs Market Share by Country (2016-2027) Figure 21. United States NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. Canada NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Europe NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe NSCLC Drugs Market Share by Type (2016-2027) Figure 25. Europe NSCLC Drugs Market Share by Application (2016-2027) Figure 26. Europe NSCLC Drugs Market Share by Country (2016-2027) Figure 27. Germany NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. France NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. U.K. NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Italy NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Russia NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Nordic NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Asia-Pacific NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific NSCLC Drugs Market Share by Type (2016-2027) Figure 35. Asia-Pacific NSCLC Drugs Market Share by Application (2016-2027) Figure 36. Asia-Pacific NSCLC Drugs Market Share by Region (2016-2027) Figure 37. China NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Japan NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. South Korea NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Southeast Asia NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. India NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Australia NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Latin America NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America NSCLC Drugs Market Share by Type (2016-2027) Figure 45. Latin America NSCLC Drugs Market Share by Application (2016-2027) Figure 46. Latin America NSCLC Drugs Market Share by Country (2016-2027) Figure 47. Mexico NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Brazil NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Middle East & Africa NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa NSCLC Drugs Market Share by Type (2016-2027) Figure 51. Middle East & Africa NSCLC Drugs Market Share by Application (2016-2027) Figure 52. Middle East & Africa NSCLC Drugs Market Share by Country (2016-2027) Figure 53. Turkey NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Saudi Arabia NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. UAE NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Merck Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 57. Bristol-Myers Squibb Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 58. Regeneron Pharmaceuticals Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 59. Novartis Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 60. Jiangsu Hengrui Medicine Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 61. Innovent Biologics Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 62. Shanghai Junshi Biosciences Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 63. BeiGene Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 64. Roche Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 65. AstraZeneca Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 66. Pfizer Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 67. Boehringer-Ingelheim Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 68. Teva Revenue Growth Rate in NSCLC Drugs Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Merck Bristol-Myers Squibb Regeneron Pharmaceuticals Novartis Jiangsu Hengrui Medicine Innovent Biologics Shanghai Junshi Biosciences BeiGene Roche AstraZeneca Pfizer Boehringer-Ingelheim Teva